Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 290863, 6 pages
http://dx.doi.org/10.1155/2014/290863
Research Article

Genetic Polymorphisms of ORAI1 and Chronic Kidney Disease in Taiwanese Population

1Division of Nephrology, Department of Medicine, Kaohsiung Medical University Hospital/Kaohsiung Medical University, Kaohsiung 807, Taiwan
2Department of Pharmacy, Taipei Medical University Hospital, Taipei 110, Taiwan
3Department of Clinical Pharmacy, College of Medicine, Taipei Medical University, Taipei 110, Taiwan
4Clinical Research Center, Taipei Medical University Hospital, Taipei 110, Taiwan
5Department of Medical Genetics, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
6Division of Nephrology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan
7Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan
8Department of Medical Genetics, College of Medicine, Taipei Medical University, Taipei 110, Taiwan
9Department of Internal Medicine, School of Medicine, Taipei Medical University, Taipei 110, Taiwan
10Department of Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan
11Faculty of Renal Care, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan

Received 13 December 2013; Accepted 6 February 2014; Published 17 March 2014

Academic Editor: Wei Chiao Chang

Copyright © 2014 Daw-Yang Hwang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. S. Levey, R. Atkins, J. Coresh et al., “Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from Kidney disease improving global outcomes,” Kidney International, vol. 72, no. 3, pp. 247–259, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. US Renal Data System (USRDS), Annual Data Report, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, Md, USA, 2009.
  3. S.-J. Hwang, J.-C. Tsai, and H.-C. Chen, “Epidemiology, impact and preventive care of chronic kidney disease in Taiwan,” Nephrology, vol. 15, supplement 2, pp. 3–9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. M. J. Landray, D. C. Wheeler, G. Y. H. Lip et al., “Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the Chronic Renal Impairment in Birmingham (CRIB) Study,” American Journal of Kidney Diseases, vol. 43, no. 2, pp. 244–253, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. B. J. G. Pereira, L. Shapiro, A. J. King, M. E. Falagas, J. A. Strom, and C. A. Dinarello, “Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients,” Kidney International, vol. 45, no. 3, pp. 890–896, 1994. View at Google Scholar · View at Scopus
  6. V. Menon, T. Greene, X. Wang et al., “C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease,” Kidney International, vol. 68, no. 2, pp. 766–772, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Herbelin, P. Urena, A. T. Nguyen, J. Zingraff, and B. Descamps-Latscha, “Elevated circulating levels of interleukin-6 in patients with chronic renal failure,” Kidney International, vol. 39, no. 5, pp. 954–960, 1991. View at Google Scholar · View at Scopus
  8. E. L. Knight, E. B. Rimm, J. K. Pai et al., “Kidney dysfunction, inflammation, and coronary events: a prospective study,” Journal of the American Society of Nephrology, vol. 15, no. 7, pp. 1897–1903, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Y. Yeun, R. A. Levine, V. Mantadilok, and G. A. Kaysen, “C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients,” American Journal of Kidney Diseases, vol. 35, no. 3, pp. 469–476, 2000. View at Google Scholar · View at Scopus
  10. M. J. Berridge, M. D. Bootman, and P. Lipp, “Calcium—a life and death signal,” Nature, vol. 395, no. 6703, pp. 645–648, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Baba, M. Matsumoto, and T. Kurosaki, “Calcium signaling in B cells: regulation of cytosolic Ca increase and its sensor molecules, STIM1 and STIM2,” Molecular Immunology, 2013. View at Publisher · View at Google Scholar
  12. P. J. Shaw and S. Feske, “Regulation of lymphocyte function by ORAI and STIM proteins in infection and autoimmunity,” The Journal of Physiology, vol. 590, part 17, pp. 4157–4167, 2012. View at Google Scholar
  13. Y. Zhou, S. Ramachandran, M. Oh-hora, A. Rao, and P. G. Hogan, “Pore architecture of the ORAI1 store-operated calcium channel,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 11, pp. 4896–4901, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Vig, W. I. DeHaven, G. S. Bird et al., “Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels,” Nature Immunology, vol. 9, no. 1, pp. 89–96, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. C. M. O'Seaghdha and C. S. Fox, “Genetics of chronic kidney disease,” Nephron - Clinical Practice, vol. 118, no. 1, pp. c55–c63, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Kottgen, N. L. Glazer, A. Dehghan et al., “Multiple loci associated with indices of renal function and chronic kidney disease,” Nature Genetics, vol. 41, no. 6, pp. 712–717, 2009. View at Google Scholar
  17. G. Genovese, D. J. Friedman, M. D. Ross et al., “Association of trypanolytic ApoL1 variants with kidney disease in African Americans,” Science, vol. 329, no. 5993, pp. 841–845, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. A. S. Levey, J. P. Bosch, J. B. Lewis, T. Greene, N. Rogers, and D. Roth, “A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation,” Annals of Internal Medicine, vol. 130, no. 6, pp. 461–470, 1999. View at Google Scholar · View at Scopus
  19. National Kidney Foundation, “K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification,” American Journal of Kidney Diseases, vol. 39, no. 2, supplement 1, pp. S1–S266, 2002. View at Google Scholar
  20. A. S. Levey, P. E. De Jong, J. Coresh et al., “The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report,” Kidney International, vol. 80, no. 1, pp. 17–28, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. P. E. Stevens and A. Levin, “Kidney disease: improving global outcomes chronic Kidney disease guideline development work group M. evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline,” Annals of Internal Medicine, vol. 158, no. 11, pp. 825–830, 2013. View at Google Scholar
  22. L. C. Ma, H. J. Chang, Y. M. Liu et al., “The relationship between health-promoting behaviors and resilience in patients with chronic kidney disease,” The Scientific World Journal, vol. 2013, Article ID 124973, 7 pages, 2013. View at Publisher · View at Google Scholar
  23. K. Kalantar-Zadeh, A. Shah, U. Duong, R. C. Hechter, R. Dukkipati, and C. P. Kovesdy, “Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals,” Kidney International, no. 117, pp. S10–S21, 2010. View at Google Scholar · View at Scopus
  24. S. Schwarz, B. K. Trivedi, K. Kalantar-Zadeh, and C. P. Kovesdy, “Association of disorders in mineral metabolism with progression of chronic kidney disease,” Clinical Journal of the American Society of Nephrology, vol. 1, no. 4, pp. 825–831, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Ketteler and P. H. Biggar, “Use of phosphate binders in chronic kidney disease,” Current Opinion in Nephrology and Hypertension, vol. 22, no. 4, pp. 413–420, 2013. View at Google Scholar
  26. J. Floege, J. Kim, E. Ireland et al., “Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population,” Nephrology Dialysis Transplantation, vol. 26, no. 6, pp. 1948–1955, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Naves-Daz, J. Passlick-Deetjen, A. Guinsburg et al., “Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. the CORES Study,” Nephrology Dialysis Transplantation, vol. 26, no. 6, pp. 1938–1947, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. G. A. Block, T. E. Hulbert-Shearon, N. W. Levin, and F. K. Port, “Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study,” American Journal of Kidney Diseases, vol. 31, no. 4, pp. 607–617, 1998. View at Google Scholar · View at Scopus
  29. G. A. Block, P. S. Klassen, J. M. Lazarus, N. Ofsthun, E. G. Lowrie, and G. M. Chertow, “Mineral metabolism, mortality, and morbidity in maintenance hemodialysis,” Journal of the American Society of Nephrology, vol. 15, no. 8, pp. 2208–2218, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. W.-C. Chang, C.-H. Lee, T. Hirota et al., “ORAI1 genetic polymorphisms associated with the susceptibility of atopic dermatitis in Japanese and Taiwanese populations,” PLoS ONE, vol. 7, no. 1, Article ID e29387, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. Y.-H. Chou, S.-H. H. Juo, Y.-C. Chiu et al., “A polymorphism of the ORAI1 gene is associated with the risk and recurrence of calcium nephrolithiasis,” Journal of Urology, vol. 185, no. 5, pp. 1742–1746, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. J. C.-C. Wei, J.-H. Yen, S.-H. H. Juo et al., “Association of ORAI1 haplotypes with the risk of HLA-B27 positive ankylosing spondylitis,” PLoS ONE, vol. 6, no. 6, Article ID e20426, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. M. J. Berridge, M. D. Bootman, and H. L. Roderick, “Calcium signalling: dynamics, homeostasis and remodelling,” Nature Reviews Molecular Cell Biology, vol. 4, no. 7, pp. 517–529, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Verkhratsky, “Calcium and cell death,” Sub-Cellular Biochemistry, vol. 45, pp. 465–480, 2007. View at Google Scholar · View at Scopus
  35. D. M. Silverstein, “Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease,” Pediatric Nephrology, vol. 24, no. 8, pp. 1445–1452, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Mochizuki, G. Wu, T. Hayashi et al., “PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein,” Science, vol. 272, no. 5266, pp. 1339–1342, 1996. View at Google Scholar · View at Scopus
  37. M. P. Winn, P. J. Conlon, K. L. Lynn et al., “Medicine: a mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis,” Science, vol. 308, no. 5729, pp. 1801–1804, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Reiser, K. R. Polu, C. C. Möller et al., “TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function,” Nature Genetics, vol. 37, no. 7, pp. 739–744, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. S. E. Dryer and J. Reiser, “TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology,” American Journal of Physiology, vol. 299, no. 4, pp. F689–F701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. D. Tian, S. M. P. Jacobo, D. Billing et al., “Antagonistic regulation of actin dynamics and cell motility by TRPC5 and TRPC6 channels (Science Signaling (2010)),” Science Signaling, vol. 3, no. 147, article er11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Greka and P. Mundel, “Balancing calcium signals through TRPC5 and TRPC6 in podocytes,” Journal of the American Society of Nephrology, vol. 22, no. 11, pp. 1969–1980, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Lu, R. Bränström, E. Berglund et al., “Expression and association of TRPC subtypes with ORAI1 and STIM1 in human parathyroid,” Journal of Molecular Endocrinology, vol. 44, no. 5, pp. 285–294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. L. M. Sherwood, I. Herrman, and C. A. Bassett, “Parathyroid hormone secretion in vitro: regulation by calcium and magnesium ions,” Nature, vol. 225, no. 5237, pp. 1056–1058, 1970. View at Publisher · View at Google Scholar · View at Scopus
  44. O. Rey, S. H. Young, R. Papazyan, M. S. Shapiro, and E. Rozengurt, “Requirement of the TRPC1 cation channel in the generation of transient Ca2+ oscillations by the calcium-sensing receptor,” The Journal of Biological Chemistry, vol. 281, no. 50, pp. 38730–38737, 2006. View at Publisher · View at Google Scholar · View at Scopus